1. Mckenna RW, Kyle RA, et al. Plasma cell neoplasms. In : Swerdlow SH, Campo E, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC;2017. p. 241–258.
2. Bingham N, Reale A, Spencer A. An evidence-based approach to myeloma bone disease. Curr Hematol Malig Rep. 2017; 12:109–118. PMID:
28243849.
3. Terpos E, Christoulas D, Gavriatopoulou M, Dimopoulos MA. Mechanisms of bone destruction in multiple myeloma. Eur J Cancer Care (Engl). 2017; 26.
4. Bassler T, Wong ET, Brynes RK. Osteitis fibrosa cystica simulating metastatic tumor. An almost-forgotten relationship. Am J Clin Pathol. 1993; 100:697–700. PMID:
8249919.
5. Ullah E, Ahmad M, Ali SA, Redhu N. Primary hyperparathyroidism having multiple brown tumors mimicking malignancy. Indian J Endocrinol Metab. 2012; 16:1040–1042. PMID:
23226663.
6. Lee JH, Chung SM, Kim HS. Osteitis fibrosa cystica mistaken for malignant disease. Clin Exp Otorhinolaryngol. 2013; 6:110–113. PMID:
23799171.
7. Zhang J, Wang H, Tian W, He Q, Zhu M. Brown tumor of the rib as a first presentation of primary hyperparathyroidism: report of three cases and literature review. Thorac Cancer. 2013; 4:474–478. PMID:
28920228.
8. Jervis L, James M, Howe W, Richards S. Osteolytic lesions: osteitis fibrosa cystica in the setting of severe primary hyperparathyroidism. BMJ Case Rep. 2017; 2017:bcr-2017-220603.
9. Bains MA, Pardoe LE, Rudin CE. Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma. Br J Haematol. 2007; 136:179. PMID:
17062009.